Adam Havey, EVP, Business Operations at Emergent BioSolutions Inc. (EBS), sold 74,558 shares at $99.02 ($7.4M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Seasonal sale ($7.4M) by EVP, Business Operations — this insider has traded EBS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.02 | 20,145 | $2.0M | 26.9% |
| 2 | $99.02 | 20,145 | $2.0M | 26.9% |
| 3 | $99.62 | 17,134 | $1.7M | 23.1% |
| 4 | $99.62 | 17,134 | $1.7M | 23.1% |
| Total | $99.30 avg | 74,558 | $7.4M | 100% |
| Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |
| EBS | SELL | 2018-11-05 | $653K | — | Filing → |